Zhejiang Xianju Pharmaceutical Co.,Ltd.

002332.SZ

002332.SZZhejiang Xianju Pharmaceutical Co.,Ltd. CN flag

Shenzhen

9.27

CNY

-0.02

(-0.22%)

0.39EPS

23.77P/E

9.17BMarket Cap

Apr 23Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

Zhejiang Xianju Pharmaceutical Co.,Ltd.

002332.SZ

(Shenzhen)

Recent

price

9.27

P/E

ratio

23.77

div

yld

3.23%

ROIC.AI

Legends:

Stock price

Beta (1.0 Market)

% total return 05/21

Stock

S&P500

-26.43

12.11

-0.43

52.58

-39.13

103.52

2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	TTM
2.24	1.94	2.2	2.57	3.06	3.2	3.1	2.74	3.18	3.97	4.07	4.38	4.41	4.43	4.17	4.03	4.02	Revenue per Share
0.16	0.16	0.17	0.16	0.08	0.07	0.13	0.16	0.23	0.33	0.45	0.55	0.63	0.76	0.57	0.4	0.39	Basic EPS, GAAP
0.11	0.12	-0.17	-0.34	-0.17	0.04	0.11	0.06	0.06	0.03	0.28	0.73	0.41	0.33	0.37	0.19	-0.24	Free Cash Flow per Basic Share
0.1	0.18	0.18	0.15	0.19	0.1	0.15	0.11	0.17	0.14	0.13	0.16	0.17	0.16	0.3	0.3	0.3	Dividend per Share
0.79	0.59	0.6	0.64	0.64	0.91	1.06	1	1.51	1.73	2.08	2.56	2.8	3.34	3.58	3.64	3.8	Book Value per Share
1.83	1.39	1.44	1.49	1.44	1.46	2.58	2.34	1.73	2.07	2.48	4.12	4.26	4.81	5.12	5.19	5.38	Tangible Book Value per Share
571	772	767	775	757	773	799	914	898	913	912	917	989	989	988	993	989	Basic Weighted Avg Shares
1,277	1,501	1,689	1,992	2,315	2,471	2,480	2,504	2,853	3,622	3,709	4,019	4,357	4,380	4,123	4,001	3,971	Sales/Revenue/Turnover
12.07	11.04	10.78	10.02	5.43	5.59	7.31	8.19	13.31	14.58	17.03	17.05	16.61	17.18	15.96	17.67	17.81	Operating Margin (%)
33	32	36	42	61	84	91	92	96	126	135	177	190	193	219	227	- -	Depreciation Expense
89	120	133	121	61	57	107	146	207	301	410	505	619	749	563	397	390	Net Income, GAAP
27.04	22.4	21.07	19.31	27.79	33.29	18.22	20.01	21.1	19.75	16.09	14.85	14.88	14.28	12.4	19.75	19.51	Effective Tax Rate (%)
6.96	8.01	7.87	6.05	2.62	2.29	4.3	5.84	7.24	8.32	11.07	12.55	14.21	17.11	13.66	9.93	9.82	Profit Margin (%)
630	683	431	156	61	59	864	761	1,085	1,115	1,109	2,125	2,186	2,465	2,353	2,486	2,611	Working Capital
- -	65	65	78	190	134	84	- -	1,090	1,071	960	588	321	198	48	31	36	LT Debt
1,100	1,121	1,154	1,203	1,182	1,228	2,153	2,237	2,386	2,710	3,059	4,582	4,950	5,507	5,830	5,888	6,073	Total Equity
8.49	7.88	8.73	9.2	4.72	4.39	5.96	5.85	8.38	9.57	11.34	10.93	10.65	11.15	9.72	9.42	9.19	Return on Invested Capital (%)
12.3	15.02	16.36	14.4	8.88	7.2	10.29	11.92	9.15	9.22	11.87	13.97	17.43	20.65	15.11	10.56	10.26	Return on Capital (%)
22.67	26.45	28.93	25.17	12.38	9.59	13.79	16.6	18.22	20.53	23.57	23.76	24.18	24.65	16.45	11.1	10.47	Return on Common Equity (%)

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	5.31%	1.7%	-2.98%
Net Income, GAAP	26.09%	2.48%	-29.46%
Free Cash Flow	109.8%	12.97%	-47.05%
Total Cash Common Dividend	19.93%	25.42%	-0.53%
Total Equity	18.83%	15.19%	1%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Similar Companies: Jubilant Pharmova Limited (JUBLPHARMA.BO)
Full Alliance Group, Inc. (FAGI)
Indivior PLC (INDV)
N4 Pharma Plc (N4P.L)
Mercury Biopharmaceutical Corporation (6932.TWO)
Acerus Pharmaceuticals Corporation (ASP.TO)
Business: Zhejiang Xianju Pharmaceutical Co.,Ltd. manufactures and sells steroids and hormones worldwide. The company offers active pharmaceutical ingredients, such as steroid drugs, and male and female hormones; intermediates; and finished formulations in the form of tablets, capsules, granules, soft capsules, powder inhalations, creams, gels, injections, and powder-injections. Zhejiang Xianju Pharmaceutical Co.,Ltd. was founded in 1972 and is based in Xianju, China.

2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	TTM
2.24	1.94	2.2	2.57	3.06	3.2	3.1	2.74	3.18	3.97	4.07	4.38	4.41	4.43	4.17	4.03	4.02	Revenue per Share
0.16	0.16	0.17	0.16	0.08	0.07	0.13	0.16	0.23	0.33	0.45	0.55	0.63	0.76	0.57	0.4	0.39	Basic EPS, GAAP
0.11	0.12	-0.17	-0.34	-0.17	0.04	0.11	0.06	0.06	0.03	0.28	0.73	0.41	0.33	0.37	0.19	-0.24	Free Cash Flow per Basic Share
0.1	0.18	0.18	0.15	0.19	0.1	0.15	0.11	0.17	0.14	0.13	0.16	0.17	0.16	0.3	0.3	0.3	Dividend per Share
0.79	0.59	0.6	0.64	0.64	0.91	1.06	1	1.51	1.73	2.08	2.56	2.8	3.34	3.58	3.64	3.8	Book Value per Share
1.83	1.39	1.44	1.49	1.44	1.46	2.58	2.34	1.73	2.07	2.48	4.12	4.26	4.81	5.12	5.19	5.38	Tangible Book Value per Share
571	772	767	775	757	773	799	914	898	913	912	917	989	989	988	993	989	Basic Weighted Avg Shares
1,277	1,501	1,689	1,992	2,315	2,471	2,480	2,504	2,853	3,622	3,709	4,019	4,357	4,380	4,123	4,001	3,971	Sales/Revenue/Turnover
12.07	11.04	10.78	10.02	5.43	5.59	7.31	8.19	13.31	14.58	17.03	17.05	16.61	17.18	15.96	17.67	17.81	Operating Margin (%)
33	32	36	42	61	84	91	92	96	126	135	177	190	193	219	227	- -	Depreciation Expense
89	120	133	121	61	57	107	146	207	301	410	505	619	749	563	397	390	Net Income, GAAP
27.04	22.4	21.07	19.31	27.79	33.29	18.22	20.01	21.1	19.75	16.09	14.85	14.88	14.28	12.4	19.75	19.51	Effective Tax Rate (%)
6.96	8.01	7.87	6.05	2.62	2.29	4.3	5.84	7.24	8.32	11.07	12.55	14.21	17.11	13.66	9.93	9.82	Profit Margin (%)
630	683	431	156	61	59	864	761	1,085	1,115	1,109	2,125	2,186	2,465	2,353	2,486	2,611	Working Capital
- -	65	65	78	190	134	84	- -	1,090	1,071	960	588	321	198	48	31	36	LT Debt
1,100	1,121	1,154	1,203	1,182	1,228	2,153	2,237	2,386	2,710	3,059	4,582	4,950	5,507	5,830	5,888	6,073	Total Equity
8.49	7.88	8.73	9.2	4.72	4.39	5.96	5.85	8.38	9.57	11.34	10.93	10.65	11.15	9.72	9.42	9.19	Return on Invested Capital (%)
12.3	15.02	16.36	14.4	8.88	7.2	10.29	11.92	9.15	9.22	11.87	13.97	17.43	20.65	15.11	10.56	10.26	Return on Capital (%)
22.67	26.45	28.93	25.17	12.38	9.59	13.79	16.6	18.22	20.53	23.57	23.76	24.18	24.65	16.45	11.1	10.47	Return on Common Equity (%)

	Sep'24	Dec'24	Mar'25
Total Current Assets	3,199	3,264	3,328
Accounts Receivable, Net	675	562	669
Cash, Cash Equivalents & STI	1,299	1,382	1,363
Inventories	895	931	922
Total Current Liabilities	738	778	717
Payables & Accruals	- -	- -	- -
ST Debt	64	28	28
Deferred Revenue	- -	- -	- -

Year	Q1	Q2	Q3	Q4	FY
2023	957	1,161	1,119	886	4,123
2024	1,038	1,100	1,099	764	4,001
2025	1,008	- -	- -	- -	- -

	Sep'24	Dec'24	Mar'25
ST Debt	64	28	28
LT Borrowings	37	20	23
LT Finance Leases	4	10	13
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	989	989	989
Market Capitalization	13,352	9,831	9,879

Zhejiang Xianju Pharmaceutical Co.,Ltd.

Growth Rates

(avg. rate of change)

Growth Rates

(avg. rate of change)

Working Capital

Capital Structure

Quarterly Revenue

Year

Quarterly Dividends Per Share

Year

Quarterly Earnings Per Share

Year